Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?

INTRODUCTION: One of the challenges of personalized medicine is a departure from traditional pharmacology toward individualized, genotype-based therapies. Postmenopausal osteoporosis is a prevalent condition requiring intensive treatment, whose effects are measurable only after a long time, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wawrzyniak, Anna, Skrzypczak-Zielińska, Marzena, Michalak, Michał, Kaczmarek-Ryś, Marta, Ratajczak, Alicja Ewa, Rychter, Anna Maria, Skoracka, Kinga, Marcinkowska, Michalina, Słomski, Ryszard, Dobrowolska, Agnieszka, Krela-Kaźmierczak, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880251/
https://www.ncbi.nlm.nih.gov/pubmed/36714573
http://dx.doi.org/10.3389/fendo.2022.1063762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880251/
https://www.ncbi.nlm.nih.gov/pubmed/36714573
http://dx.doi.org/10.3389/fendo.2022.1063762

Ejemplares similares